Home
Conditions
Myeloproliferative Disorder

Clinical trial condition

Myeloproliferative Disorder

Explore clinical trials studying Myeloproliferative Disorder. Study availability and eligibility vary by location and protocol.

21 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Disorder trial results

Completed

Evaluation of Formin Gene Status and Expression in Myeloproliferative and Myelodysplastic Disorders

NCT00687414

Conditions: AML, Bone Marrow Diseases, Hematologic Diseases, +4 more
Locations: St Mary's Health Care Grand Rapids, Michigan, United States

Van Andel Research Institute Grand Rapids, Michigan, United States

View Trial Details

Completed

Preventing Stem Cell Transplant Complications With a Blood Separator Machine

NCT01866839

Conditions: ALL (Acute B-Lymphoblastic Leukemia), AML (Acute Myelogenous Leukemia, Anemia, +29 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase

NCT03907436

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +19 more
Locations: University of California, Irvine Irvine, California, United States

View Trial Details

Completed

Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative Neoplasms

NCT03688490

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Not specified

View Trial Details

Completed

Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies

NCT01499147

Conditions: Acute Leukemia, Acute Myeloid Leukemia, Anemia, +51 more
Locations: University of Illinois at Chicago Medical Center Chicago, Illinois, United States

View Trial Details

Completed

Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD

NCT00539695

Conditions: ALL, AML, Acute Lymphoblastic Leukemia, +31 more
Locations: Texas Children's Hospital Houston, Texas, United States

The Methodist Hospital Houston, Texas, United States

View Trial Details

Completed

Primary Thrombocythaemia 1 Trial

NCT00175838

Conditions: Blood Platelet Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +12 more
Locations: Addenbrooke's Hospital Cambridge, Cambs, United Kingdom

View Trial Details

Completed

T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies

NCT00683046

Conditions: Acute Myelogenous Leukemia, Anemia, Anemia, Aplastic, +41 more
Locations: The University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders

NCT00533923

Conditions: ALL, AML, Anemia, +34 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma

NCT00588666

Conditions: Bone Marrow Diseases, Cancer, Carcinoma, +9 more
Locations: Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States

Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States

Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Myeloproliferative Disorder

Myeloproliferative Disorder trial results

Related conditions